Perspectives on the Current Oncology Value-Based Care Landscape from the NCCN Policy Summit

October 2019

On September 12, Discern attended the National Comprehensive Cancer Network (NCCN) Policy Summit: Defining, Measuring, and Applying Quality in an Evolving Health Policy Landscape and the Implications for Cancer Care. The summit presented diverse perspectives related to defining, measuring, and paying for quality as cancer care is inundated with innovative, personalized, and high-cost interventions.

Experts in the field discussed the role of outcomes-based oncology quality measures in policy decision-making, including how the patient experience is considered and applied in clinical decision-making. The summit also evaluated how clinical utility and personalized medicine outcomes shape the health care system. Key themes from the discussion include increasing drug costs, the impact and sustainability of the Oncology Care Model, and the current role and future implications of quality measurement.

Download a summary of the summit here.

Download the Rising Drug Costs: Challenges in Controlling Overall Cost of Care presentation slides here and The Role of Standardized Performance Measures in Ensuring Quality in Cancer Care presentation slides here.

For more information, please contact Gracelena Ignacio at gignacio@discernhealth.com.

Discern expands Health Economics and Outcomes Research (HEOR) Capabilities For Life Sciences clients

Health economics and outcomes research (HEOR) has long been important for health care market access outside the U.S., but it is increasingly being utilized in the U.S. as part of the movement from vol...
Learn More

About

About

Capabilities

Capabilities

Contact

Contact Us

Insights

Insights

Guy D’Andrea Speaks About Innovative Payment Models

Click here to view the VIDEO